Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01676259
Title A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer (PROTACT)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Silenseed Ltd

pancreatic cancer


Gemcitabine + Nab-paclitaxel + siG12D-LODER

Gemcitabine + Nab-paclitaxel

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.